RORgammat inverse agonist 35 (Compound 22) is a RORgammat inverse agonist with an IC50 of 1.51 µM. RORgammat inverse agonist 35 significantly inhibits Th17 differentiation and proinflammatory properties in human CD4+ T cells. RORgammat inverse agonist 35 can be used for research of Th17-driven autoimmune diseases, such as psoriasis, multiple sclerosis, and inflammatory bowel disease (IBD)[1].
Molecular Weight:
450.53
Formula:
C25H23FN2O3S
Target:
Interleukin Related,ROR
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
